Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 459
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 112
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 95
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 35
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
HIV/AIDS Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

2,422 Results (Page 9 of 122)
- Relevance
  Sort by

Kaposi Sarcoma - Global Strategic Business Report

 Report
August 2025
309 Pages
Global

From

€5238EUR$5,850USD£4,559GBP

Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Radiation Therapy, Immunotherapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
110 Pages
Global

From

€5328EUR$5,950USD£4,637GBP

Cervical Cancer Vaccine Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4020EUR$4,490USD£3,499GBP

Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
532 Pages
Global

From

€2239EUR$2,500USD£1,948GBP

Bladder Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4020EUR$4,490USD£3,499GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Kidney Cancer Therapeutics and Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
140 Pages
Global

From

€4253EUR$4,750USD£3,702GBP

US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028

 Report
February 2022
360 Pages
United States

From

€2901EUR$3,240USD£2,525GBP

€3224EUR$3,600USD£2,806GBP

Urothelial Carcinoma Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4020EUR$4,490USD£3,499GBP

Urinary Tract Cancer Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4020EUR$4,490USD£3,499GBP

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
382 Pages
Global

From

€1791EUR$2,000USD£1,559GBP

Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology and Market Forecast - 2034

 Report
August 2024
265 Pages
Global

From

€7119EUR$7,950USD£6,196GBP

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027

 Report
November 2022
119 Pages
Global

From

€3537EUR$3,950USD£3,078GBP

Kidney Cancer Therapeutics and Diagnostics Market Report by Component, Cancer Types, Application, and Region 2025-2033

 Report
January 2025
125 Pages
Global

From

€2685EUR$2,999USD£2,337GBP

Endocrinology Drugs Market by Therapy Area, Distribution Channel, and By Region

 Report
March 2024
200 Pages
Global

From

€3716EUR$4,150USD£3,234GBP

Bladder Cancer Therapeutics and Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€4029EUR$4,500USD£3,507GBP

Cancer Monoclonal Antibodies Market Report by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033

 Report
February 2025
144 Pages
Global

From

€2685EUR$2,999USD£2,337GBP

Collaboration Deals in Pharmaceuticals 2019-2025

 Report
April 2025
950 Pages
Global

From

€3577EUR$3,995USD£3,113GBP

Licensing Deals in Pharmaceuticals 2019-2025

 Report
April 2025
1400 Pages
Global

From

€4473EUR$4,995USD£3,893GBP

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region

 Report
October 2023
145 Pages
Global

From

€2821EUR$3,150USD£2,455GBP

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025

 Clinical Trials
July 2025
80 Pages
Global

From

€1791EUR$2,000USD£1,559GBP

2,422 Results (Page 9 of 122)
- 1
- 7
- 8
- 9
- 10
- 11

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.